about
COPD and osteoporosis: links, risks, and treatment challengesPINP as a biological response marker during teriparatide treatment for osteoporosisBone metabolism in children and adolescents: main characteristics of the determinants of peak bone massNovel biological markers of bone: from bone metabolism to bone physiologyOsteoporosis Associated with Chronic Obstructive Pulmonary DiseaseFood fortification for bone health in adulthood: a scoping reviewUpdate on primary ovarian insufficiency(-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent mannerAdditive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study.Osteoporosis, fractures, and diabetes.Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in miceBone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS).Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfectaBiochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control studyThe biological effects of tocotrienol on bone: a review on evidence from rodent models.Bone remodeling markers and bone metastases: From cancer research to clinical implicationsEffect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivorsThe effects of dopamine receptor 2 expression on B cells on bone metabolism and TNF-α levels in rheumatoid arthritisFortification of Yogurts with Vitamin D and Calcium Enhances the Inhibition of Serum Parathyroid Hormone and Bone Resorption Markers: A Double Blind Randomized Controlled Trial in Women over 60 Living in a Community Dwelling HomeA Metabolic Study of Huntington's Disease.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksQuantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.Mulberry water extract regulates the osteoblast/osteoclast balance in an ovariectomic rat model.Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.The Utility of Biomarkers in Osteoporosis Management.Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.Biomarkers Predicting Bone Turnover in the Setting of CKD.Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal studyUrinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause.Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis.IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression.Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
P2860
Q26751371-844C447F-CAB0-4C69-B52C-528438C21540Q26859267-F0083D81-7815-41FB-A3BA-261EF5D319AAQ26996397-FC76E633-BA5C-4D01-95B7-212BAA067C70Q28067712-D1C7A0E7-1E99-4E3C-9210-D3D253761F34Q28070018-1890A2DF-503F-4F98-88C2-6DA164B2CD80Q28072047-868D268A-A831-4915-A210-E93D4FE984D5Q28085503-C4D428B6-8236-4501-88C9-91F55225432BQ33634836-3C560339-76E7-4EE4-B549-23E305649140Q33676779-6883EFAE-0837-47E1-B754-01FEACC9C485Q33890224-BDC93E74-6565-4289-8B97-FB8C86B51850Q33891378-F0725137-9467-4687-8ADC-9C3CA7A44EF5Q34035048-68470B5F-3EC1-4800-9779-F3E6F2377A1DQ34278522-8272E6E5-291B-4355-9402-0408179CE169Q34429959-FCF86C0D-5351-4991-90E5-536F7E23FE24Q34438834-A600EE01-70A2-4E4F-A01A-A3A058D3F114Q34485335-2FC25661-9737-4897-A5B8-A7FE2068D122Q34544274-B664F7A8-1A6B-4448-87D6-73FF6E2E8A58Q35017714-AC2DA6F6-FE4D-45AF-8C7B-4CD0D6E2516CQ35068151-4116D320-6D44-4806-8360-D588449FD218Q35410229-57E8BAB9-A7E1-4A52-A777-12CCB6529C18Q35531006-4B08A2DD-4C61-4FFA-BBDB-E7C2F98C4C2CQ35907788-70783956-168B-403D-A76A-CE2DFAD1154DQ36108132-59E876D1-B8D0-405B-85D7-E944EBC6A360Q36378579-4233F07B-0CAF-4C51-9E48-6ED237BE1252Q36445216-1B0DFF95-574B-4BDF-BE08-3955D4E077EDQ36648170-8240C710-8E14-4C35-941A-7D983D675590Q37057960-6A06D519-8064-4823-B6ED-695379166889Q38310689-FCB98026-0808-4ECB-BA91-45E4FC2C19BEQ38734163-B3A5F184-1FEB-4E1C-87D8-90123C3A257EQ38813290-D62416F6-3C03-4C88-B703-369CFEBA0253Q38921875-7A3C5F65-B3F5-4AC0-A58B-F3A7A9C09384Q39162467-3D1DEE89-42D6-466C-97E0-E702F23BFFCAQ39254025-0876338E-3941-4217-B521-E88BDF81BF25Q39656951-FD7D48CF-5362-4057-BBF7-C71DBB23E66DQ40528709-5D6C3F4B-9FD6-47E3-A743-C19F6A0B9D8CQ40536031-3DF53C8F-20E4-4967-A701-6EA548ED6BD1Q40605141-4A6AB4C3-890D-42CC-8F67-74FBCC5490F5Q40772428-3EA3E1BB-D592-4971-9428-A9C816445956Q40828040-57568474-B4EF-4EFC-8AAE-A382768FF9DEQ41989650-A03ED4CF-54E5-4170-904D-30189F8AFB94
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bone turnover markers: use in osteoporosis.
@en
type
label
Bone turnover markers: use in osteoporosis.
@en
prefLabel
Bone turnover markers: use in osteoporosis.
@en
P2860
P356
P1476
Bone turnover markers: use in osteoporosis.
@en
P2093
Kim Naylor
Richard Eastell
P2860
P2888
P304
P356
10.1038/NRRHEUM.2012.86
P407
P577
2012-06-05T00:00:00Z
P5875
P6179
1015580657